Intralesional cidofovir for recurrent respiratory papillomatosis in children.

OBJECTIVE To assess the potential benefit of intralesional administration of cidofovir, an acyclic nucleoside phosphonate with activity against several DNA viruses, for treating severe respiratory papillomas in pediatric patients. DESIGN Prospective case series. SETTING Tertiary care children's hospitals. PATIENTS Five pediatric patients with severe recurrent respiratory papillomatosis requiring laryngoscopy with carbon dioxide laser therapy more frequently than once a month to maintain airway patency. Each patient underwent between 12 and 33 laryngoscopies with laser treatment prior to being injected with cidofovir. INTERVENTION Microsuspension laryngoscopy with intralesional injection of cidofovir (Vistide) in conjunction with mechanical debulking and carbon dioxide laser of papillomas. MAIN OUTCOME MEASURE Papilloma stage at time of serial laryngoscopies. RESULTS One patient was disease free and 3 patients demonstrated a dramatic response to adjuvant therapy with cidofovir at the 9-month follow-up visit after the last injection of cidofovir. One patient showed an improvement in papilloma stage that was possibly related to concurrent therapy with interferon. CONCLUSIONS Intralesional injection of cidofovir seems to be of benefit in the treatment of severe respiratory papillomatosis in pediatric patients. Larger prospective studies with longer follow-up will be required before cidofovir can be considered an accepted means of managing this difficult disease.

[1]  C. Derkay Recurrent Respiratory Papillomatosis , 2001, The Laryngoscope.

[2]  E. De Clercq,et al.  Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine] , 1998, Journal of medical virology.

[3]  J. Mulliken,et al.  Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy , 1998, The Journal of pediatrics.

[4]  B. Kuppermann,et al.  Intravenous Cidofovir for Peripheral Cytomegalovirus Retinitis in Patients with AIDS , 1997, Annals of Internal Medicine.

[5]  R. Smith,et al.  Recurrent respiratory papillomatosis. , 1996, Pediatric clinics of North America.

[6]  C. Desloovere,et al.  Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir®) , 1996 .

[7]  E. De Clercq Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. , 1996, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

[8]  G. Singleton,et al.  Adjuvant Drug Strategies in the Treatment of Recurrent Respiratory Papillomatosis , 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[9]  P. Rutgeerts,et al.  Successful treatment of a squamous papilloma of the hypopharynx‐esophagus by local injections of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine , 1995, Journal of medical virology.

[10]  Richard J. H. Smith,et al.  Acyclovir in the Treatment of Recurrent Respiratory Papillomatosis , 1994, The Annals of otology, rhinology, and laryngology.

[11]  P. Rutgeerts,et al.  Successful treatment of human papillomavirus (HPV) associated giant squamous papilloma of the hypopharynx and esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) , 1994 .

[12]  R. Mcglennen,et al.  Pilot trial of ribavirin for the treatment of laryngeal papillomatosis , 1993, Head & neck.

[13]  R. Hruban,et al.  Sites of Predilection in Recurrent Respiratory Papillomatosis , 1993, The Annals of otology, rhinology, and laryngology.

[14]  J. C. Martin,et al.  Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. , 1992, Molecular pharmacology.

[15]  B. Steinberg,et al.  Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. , 1992, Archives of otolaryngology--head & neck surgery.

[16]  H. Kashima,et al.  Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-n1 , 1991 .

[17]  R. Gelber,et al.  Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. , 1988, The New England journal of medicine.

[18]  V. F. Righthand,et al.  Persistence of echovirus 6 in cloned human cells , 1985, Journal of virology.